Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, August 8, 2022
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
Fri, August 5, 2022
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
Justin Kim Downgraded (BCRX) to Hold on, Aug 5th, 2022
Justin Kim of Oppenheimer, Downgraded "BioCryst Pharmaceuticals, Inc." (BCRX) to Hold on, Aug 5th, 2022.
Justin has made no other calls on BCRX in the last 4 months.
There are 2 other peers that have a rating on BCRX. Out of the 2 peers that are also analyzing BCRX, all agree with Justin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $14 on, Tuesday, April 12th, 2022
- Tazeen Ahmad of "B of A Securities" Downgraded from Strong Buy to Hold and Held Target at $14 on, Monday, April 11th, 2022
